Repurposing BCL-2 and Jak 1/2 inhibitors: Cure and treatment of HIV-1 and other viral infections
B cell lymphoma 2 (BCL-2) family proteins are involved in the mitochondrial apoptotic pathway and are key modulators of cellular lifespan, which is dysregulated during human immunodeficiency virus type 1 (HIV-1) and other viral infections, thereby increasing the lifespan of cells harboring virus, in...
Main Authors: | Monica D. Reece, Colin Song, Sarah C. Hancock, Susan Pereira Ribeiro, Deanna A. Kulpa, Christina Gavegnano |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-12-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2022.1033672/full |
Similar Items
-
The comorbidity of depression and neurocognitive disorder in persons with HIV infection: call for investigation and treatment
by: Karl Goodkin, et al.
Published: (2023-04-01) -
A Rationale and Approach to the Development of Specific Treatments for HIV Associated Neurocognitive Impairment
by: Aaron Scanlan, et al.
Published: (2022-11-01) -
Readily available drugs and other interventions to potentially improve the efficacy of immune checkpoint blockade in cancer
by: Merissa Coleman, et al.
Published: (2024-01-01) -
Prime, shock and kill: BCL-2 inhibition for HIV cure
by: Aswath P. Chandrasekar, et al.
Published: (2022-10-01) -
IFNγ induces Bcl3 expression by JAK1/STAT1/p65 signaling, resulting in increased IL‐8 expression in ovarian cancer cells
by: Bijaya Gaire, et al.
Published: (2023-08-01)